$USA

Earnings call transcript: USA Rare Earth Q2 2026 revenue miss sparks selloff

USA Rare Earth reported Q2 2026 revenue of about $5.82 million versus a Wall Street forecast of $8 million, while adjusted EPS matched expectations at a loss of 15 cents. The company said revenue came entirely from Less Common Metals. Shares fell to $19.04 in regular trading and to $17.32 after hours. Cash was about $1.5 billion.

Original reporting
Published Aug 10, 2026, 10:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 11:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$USA
Bearish
high confidence
Mentioned
$USA
Relevance
9/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$USABearishHigh
01

Why it matters

The key tradable takeaway is the gap between revenue and forecast, which can change expectations for how quickly milestones translate into sales, even when adjusted EPS is in line.

02

Market read

A revenue miss with in-line adjusted EPS triggered a large after-hours drop, making near-term sales conversion and milestone-to-revenue timing the focus.

03

What to watch

The company attributes revenue entirely to Less Common Metals and notes cost shifts into inventory plus higher pricing on some products, which could support later-quarter catch-up.

Relevance 9/10Novelty 8/10Timing: after-hours reaction to Q2 2026 earnings call transcript (published pre-late session)

Background

USA Rare Earth is building a vertically integrated rare earth platform and is in a commercialization ramp with heavy spending and continued losses.

Company-level read

Ticker impact

$USABearishHigh confidence
Context

USA Rare Earth reported Q2 2026 revenue of about $5.82M versus $8M forecast, driving a sharp after-hours selloff.

Expected impact

Bearish bias for near-term trading until follow-through on magnet sales timing and pricing momentum is evidenced.

Evidence & confidence

The article cites a large revenue shortfall (27.25% below forecast) as the dominant driver of the after-hours decline, while EPS matched expectations.

Market effects

Highlights execution and commercialization timing risk for non-China rare earth supply chain plays, even when pricing momentum is improving.

No specific regional market impact beyond US-listed rare earth equities sentiment.

Reinforces the broader non-China rare earth supply narrative, but with near-term demand conversion uncertainty.

Counterpoint

Investors may be over-weighting a single-quarter revenue miss while discounting that adjusted EPS matched and management expects first magnet sales by year-end 2026.

Key entities

  • USA Rare Earth

    Reported Q2 2026 revenue of about $5.82M vs $8M forecast; after-hours shares fell ~9% on the sales shortfall.

  • Barbara Humpton

    CEO commentary emphasized availability-driven rare earth market and strategy to build a complete non-China chain.

  • Thras Moraitis

    Set to succeed Barbara Humpton as CEO on Oct. 1.

  • Serra Verde acquisition

    Shareholder vote scheduled for Aug. 28, described as the last major hurdle.

Related articles

$LXPMed

Dow Jones Top Company Headlines at 9 AM ET: Brookfield and CPP Investments to Buy LXP Industrial for $5.2 Billion |

Brookfield Asset Management and Canada Pension Plan Investment Board agreed to buy LXP Industrial Trust in an all-cash deal valued at about $5.2 billion. Other headlines include Jersey Mike’s IPO terms targeting about $8 billion market cap, Domino’s profit of $135.8 million ($4.07/share), and BP selling its Austrian mobility retail business to Volenergy.

$MPMed

Washington’s five-week rare earths funding surge: how the US is rebuilding a supply chain outside China

From June 2-26, 2026, the US committed about $2.9B in direct federal funding to expand rare earths and permanent magnet supply chains outside China, led by Commerce’s CHIPS Act. Companies added $1.4B. DOD and DOE also issued loans and ARPA-E research funding, while the Army opened bases for processing. USA Rare Earth, Energy Fuels, Phoenix Tailings, Empire State Mines, EnergyX, Ioneer, and REalloys were named.

$NVDAMed

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Broadcom, Microsoft, IBM, Meta, Tyson Foods & more

Wall Street analysts issued multiple calls Monday. Goldman initiated HawkEye 360 as buy; Morgan Stanley upgraded Dell to equal weight; Wells Fargo upgraded Tandem Diabetes Care to overweight. Citizens initiated Microsoft at Market Outperform with a $550 target; Barclays initiated IBM at overweight with a $350 target. Cantor reiterated Tesla overweight; RBC reiterated Meta outperform. Broadcom was reiterated overweight by Morgan Stanley, raising its target to $485.

$USAMedAI 8/10

Brazil Is Set to Cut into China's Rare Earths Dominance

Brazil is ramping up rare-earth development as demand for magnet metals rises for EVs, wind turbines and AI-related tech, the IEA says. Meteoric Resources is investing in its Caldeira ionic clay project in Minas Gerais. Brazil has ~21 million tons of reserves vs China’s ~44 million. Stocks of rare-earth miners have gained 65%-122% in 12 months; USA Rare Earths bought Brazil’s only active mine for $2.8 billion.

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.